This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Helicobacter Pylori Infection
and you are
between 18 and 60
years old
The phase for this study is not defined.
Show me locations

The purpose

Addition of L. reuteri to the standard triple therapy improves H. Pylori treatment outcomes.

Provided treatments

  • : Lactobacillus reuteri
  • : Placebo
  • Drug: Omeprazole
  • Drug: Amoxicillin
  • Drug: Clarithromycin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593592. The sponsor of the trial is Zagazig University and it is looking for 70 volunteers for the current phase.
Official trial title:
Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients: a Double Blind Placebo Controlled Randomized Clinical Trial